Evidence map›Paper›PMID 28365916›Full record

ArticleDigestive diseases and sciences2017

Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.

Takafumi Yoshida, Jun Akiba, Takanori Matsui, Kazuo Nakamura, Takao Hisamoto, Mitsuhiko Abe, Yu Ikezono, Fumitaka Wada, Hideki Iwamoto, Toru Nakamura and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Elevated LECT2 and PEDF in Pediatric MAFLD: Diagnostic Performance and Metabolic Correlations.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  4. Article
  5. Article
  6. Antagonism Between PEDF and TGF-β Contributes to Type VI Osteogenesis Imperfecta Bone and Vascular Pathogenesis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Reply to "The Connection between Celiac Disease and Hepatic Steatosis: High Levels of Pigment Epithelium-Derived Factor".Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2020
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Takafumi YoshidaDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. tayoshi@med.kurume-u.ac.jp.ORCID 0000-0001-6806-6215
Jun AkibaDepartment of Diagnostic Pathology, Kurume University School of Medicine, Kurume, Japan.
Takanori MatsuiDepartment of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.
Kazuo NakamuraNakamura Clinic, Wakamatsu-ku, Kitakyushu, Japan.
Takao HisamotoDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Mitsuhiko AbeDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Yu IkezonoDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Fumitaka WadaDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Hideki IwamotoDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Toru NakamuraDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Hironori KogaDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Sho-Ichi YamagishiDepartment of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.
Takuji TorimuraDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Kurume University · JPThe Nakamura Hajime Eastern Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsPigment epithelium-derived factor (PEDF) has been shown to be a potent inhibitor of inflammation through its anti-oxidative property. Since oxidative response is considered to play the pivotal role of the development and progression of nonalcoholic steatohepatitis (NASH), it is conceivable that PEDF may play a protective role against NASH. In this study, we examined whether administration of PEDF slowed the progression of NASH in mice models.

methodsMice were fed methionine- and choline-deficient (MCD) diet with or without intramuscular administration of adenovirus-expressing PEDF (Ad-PEDF). Effects of PEDF administration on NASH were histologically and biochemically evaluated.

resultsAdministration of Ad-PEDF significantly decreased hepatic fat storage as well as serum levels of ALT in MCD diet-fed mice. Dihydroethidium staining showed that MCD diet-triggered oxidative stress was reduced in the liver of Ad-PEDF-administered mice compared to that of PBS- or Ad-LacZ-administered mice. Activation of Kupffer cells and hepatic fibrosis was also inhibited by Ad-PEDF administration. Quantitative real-time RT-PCR revealed that MCD diet up-regulated expressions of TNF-α, IL-1β, IL-6, TGF-β, collagen-1, and collagen-3 mRNA, which were also attenuated with Ad-PEDF administration, whereas MCD diet-induced down-regulation of expressions of PPAR-γ mRNA was restored with Ad-PEDF administration. Furthermore, immunoblotting analysis showed that MCD diet-induced up-regulation of NADPH oxidase components was significantly decreased in Ad-PEDF-administered mice.

conclusionsThe present results demonstrated for the first time that PEDF could slow the development and progression of steatohepatitis through the suppression of steatosis and inflammatory response in MCD diet-fed mice. Our study suggests that PEDF supplementation may be a novel therapeutic strategy for the treatment of NASH.

Indexed as

AdenoviridaeAdipose TissueAlanine TransaminaseAnimalsCholine DeficiencyCollagen Type ICollagen Type IIIDietDisease Models, AnimalDown-RegulationEye ProteinsFatty LiverInjections, IntramuscularInterleukin-1betaInterleukin-6Kupffer CellsAlanine TransaminaseCollagen Type ICollagen Type IIIEye ProteinsInterleukin-1betaInterleukin-6MethionineNADPH OxidasesNerve Growth FactorsPigment Epithelium-Derived FactorPPAR gammaProtease InhibitorsRNA, MessengerSerpinsTumor Necrosis Factor-alphaOxidative stressPigment epithelium-derived factorSteatohepatitis

Identifiers

PMID28365916
OpenAlexW2599852311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.